AuntMinnie

MARCH 7, 2024

In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PET scans per fixed PET site (versus mobile PET) increased 6.7%

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

AuntMinnie

OCTOBER 13, 2023

Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PET scans will now be made by local Medicare Administrative Contractors (MACs).

Nuclear Medicine 116

Nuclear Medicine PET Scan Medicare Disease 116

AuntMinnie

APRIL 15, 2024

FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. “In

Nuclear Medicine 122

Nuclear Medicine PET Scan Hospital Clinic 122

AuntMinnie

JANUARY 23, 2024

An international survey of treatment centers has revealed significant differences in several aspects of Lu-177 PSMA-617 prostate cancer therapy, including patient imaging protocols, according to a study published January 18 in the Journal of Nuclear Medicine. In addition, different PET radiotracers are used.

Nuclear Medicine 98

Nuclear Medicine PET Scan Imaging Clinic 98

Imaging Technology

MAY 31, 2023

Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. v] Up to 53% reduction of PET scan time on Omni Legend 32 cm compared to Discovery MI 25 cm, as demonstrated in phantom testing. [vi] Gallen in Switzerland [vii]. ix Mehranian, A.,

Nuclear Medicine 98

Nuclear Medicine Healthcare Healthcare IT 98

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52